| 000 | 01718 a2200409 4500 | ||
|---|---|---|---|
| 005 | 20250516184128.0 | ||
| 264 | 0 | _c20150518 | |
| 008 | 201505s 0 0 eng d | ||
| 022 | _a1433-2965 | ||
| 024 | 7 |
_a10.1007/s00198-013-2585-1 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aGanda, K | |
| 245 | 0 | 0 |
_aRapid biochemical response to denosumab in fibrous dysplasia of bone: report of two cases. _h[electronic resource] |
| 260 |
_bOsteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA _cFeb 2014 |
||
| 300 |
_a777-82 p. _bdigital |
||
| 500 | _aPublication Type: Case Reports; Journal Article | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aAntibodies, Monoclonal, Humanized _xpharmacology |
| 650 | 0 | 4 |
_aBiomarkers _xblood |
| 650 | 0 | 4 |
_aBone Density Conservation Agents _xtherapeutic use |
| 650 | 0 | 4 |
_aBone Remodeling _xdrug effects |
| 650 | 0 | 4 | _aDenosumab |
| 650 | 0 | 4 |
_aDiphosphonates _xtherapeutic use |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aFibrous Dysplasia of Bone _xblood |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aImidazoles _xtherapeutic use |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aRANK Ligand _xantagonists & inhibitors |
| 650 | 0 | 4 | _aTreatment Failure |
| 650 | 0 | 4 | _aTreatment Outcome |
| 650 | 0 | 4 | _aZoledronic Acid |
| 700 | 1 | _aSeibel, M J | |
| 773 | 0 |
_tOsteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA _gvol. 25 _gno. 2 _gp. 777-82 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1007/s00198-013-2585-1 _zAvailable from publisher's website |
| 999 |
_c23341443 _d23341443 |
||